Allelica
Allelica provides clinical polygenic risk score (PRS) tests that identify individuals at elevated risk for cardiovascular disease and cancer to support prevention and screening. The company produces genomics software and validated diagnostic infrastructure that applies PRS models, machine learning and multi-ancestry genetic reference data to deliver clinically actionable risk estimates. Allelica operates as a B2B genomics software and diagnostics provider, enabling clinical genetics laboratories and biopharma partners to deploy tests via cloud-based or on-premise implementations. Its work follows clinical and regulatory best practices, and its research has been published in peer-reviewed journals and presented at major conferences. Allelica targets healthcare institutions and laboratories seeking validated, production-ready PRS analytics for clinical use.
Allelica
Allelica provides clinical polygenic risk score (PRS) tests that identify individuals at elevated risk for cardiovascular disease and cancer to support prevention and screening. The company produces genomics software and validated diagnostic infrastructure that applies PRS models, machine learning and multi-ancestry genetic reference data to deliver clinically actionable risk estimates. Allelica operates as a B2B genomics software and diagnostics provider, enabling clinical genetics laboratories and biopharma partners to deploy tests via cloud-based or on-premise implementations. Its work follows clinical and regulatory best practices, and its research has been published in peer-reviewed journals and presented at major conferences. Allelica targets healthcare institutions and laboratories seeking validated, production-ready PRS analytics for clinical use.